http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113736731-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-119 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-90 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0667 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 |
| filingDate | 2021-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113736731-B |
| titleOfInvention | Serum-free medium of adipose tissue-derived mesenchymal stem cells and preparation method and application thereof |
| abstract | The application belongs to the technical field of cell culture media, and particularly relates to a serum-free medium of adipose tissue-derived mesenchymal stem cells, a preparation method of the serum-free medium, and application of the serum-free medium of adipose tissue-derived mesenchymal stem cells. The serum-free culture medium of the adipose tissue-derived mesenchymal stem cells comprises a basic culture medium and additives; wherein the basal medium comprises DMEM/F12 medium; the additive comprises transferrin, recombinant human insulin, fibroblast growth factor, fibronectin, astragaloside IV, radix Codonopsis extract and aloe extract. The serum-free culture medium is used for culturing adipose-derived mesenchymal stem cells, and can promote the growth and proliferation of the adipose-derived stem cells, reduce cell damage and improve the survival rate of the cells through the synergistic effect of all components, so that the in-vitro amplification capacity of the adipose-derived stem cells is improved. And has no heterologous pollution, no potential safety hazard causing rejection reaction, stable culture medium performance and reliable quality. |
| priorityDate | 2021-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 141.